Medicare Drug Price Negotiations

This chapter discusses Medicare's drug price negotiations under the Inflation Reduction Act, examining projected savings and industry reactions. It also covers upcoming changes to the Medicare Part D benefit, including a $2,000 annual cap on out-of-pocket spending and the challenges of predicting consumer behavior in this evolving landscape.